Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists
(MedPage Today) -- Several years after initiating treatment, GLP-1 receptor agonist users didn't have a pancreatic cancer safety signal, a historical cohort study reported.
Compared with basal insulin users, those on a GLP-1 receptor agonist didn...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | History of Medicine | Insulin | Pancreas | Pancreatic Cancer | Study